miRNAs in Cardiovascular Biology

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

January 21, 2022
Comment / Editorial
Open Access

Editorial Research Topic: Non-coding RNA as Therapeutic Target: A Game Changer in Cardiac Regenerative Strategies?

Frontiers in Physiology
Julia Leonardy, Christian Bär
January 21, 2022
Review

MicroRNAs in Obesity-Associated Disorders: The Role of Exercise Training.

Obesity Facts
Andre SilveiraEdilamar Menezes de Oliveira
January 20, 2022
Review

Rho Kinases in Embryonic Development and Stem Cell Research.

Archivum Immunologiae Et Therapiae Experimentalis
Jianjian Shi, Lei Wei
January 19, 2022
Open Access

miR-548j-5p regulates angiogenesis in peripheral artery disease.

Scientific Reports
Chiu-Yang LeeTao-Cheng Wu
January 19, 2022

Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.

Clinical and Experimental Medicine
Fengchuan JingQijian Yi
January 14, 2022
Review

On-going consequences of in utero exposure of Pb: An epigenetic perspective.

Journal of Applied Toxicology : JAT
Fahim Rejanur TasinChanchal Mandal
January 14, 2022
Review

The Role of MicroRNAs in Thrombosis.

Advances in Experimental Medicine and Biology
Christos Yapijakis
January 13, 2022

Relationship between circulating miRNA-21, atrial fibrosis, and atrial fibrillation in patients with atrial enlargement.

Annals of Palliative Medicine
Hao ChenXin-Chun Yang
January 13, 2022

Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria.

Aging
Christina ManakanatasSelma Osmanagic-Myers
January 12, 2022
Review

Role of circulating molecules in age-related cardiovascular and metabolic disorders.

Inflammation and Regeneration
Yung Ting HsiaoTohru Minamino
January 11, 2022
Review

Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.

Journal of cardiology
Tao ZhangKuihao Chen
January 11, 2022
Review

Targeting cardiomyocyte proliferation as a key approach of promoting heart repair after injury.

Molecular Biomedicine
Shuainan LiBenzhi Cai
January 7, 2022
Review
Open Access

Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics.

Frontiers in Genetics
Jinhong ChenXufang Gu
January 7, 2022
Open Access

Expression Profiles of Circular RNA in Aortic Vascular Tissues of Spontaneously Hypertensive Rats.

Frontiers in Cardiovascular Medicine
Ying LiuJiuchang Zhong

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2022 Meta ULC. All rights reserved
/feed-previews/mirnas-in-cardiovascular-biology/93b5f618-03e6-4a05-937c-b49ef4db2578